SCHEMBL8220657

SCHEMBL8220657

O=C(NCc1ccccc1)Nc1c[nH]nc1C(=O)NC1CCC(O)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.46
HPGD P15428 1/20 0.46
BRD4 O60885 2/20 0.43
DRD4 P21917 1/20 0.42
CFD P00746 1/20 0.42
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
GAA P10253 1/20 0.41
GSK3B P49841 1/20 0.41
RAB9A P51151 2/20 0.41
POLB P06746 1/20 0.41
NPC1 O15118 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NAMPT P43490 4/20 0.41
ROCK2 O75116 1/20 0.40
CCR3 P51677 1/20 0.40
MAPK1 P28482 1/20 0.40
MFN2 O95140 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12000436 1.00 EPHX1 (0.46) EPHX1HPGDBRD4DRD4CFD
SCHEMBL8212906 0.85 EPHX2 (0.44) EPHX1BRD4KDM4EALDH1A1RAB9A
SCHEMBL8216567 0.85 EPHX2 (0.44) EPHX1BRD4KDM4EALDH1A1RAB9A
SCHEMBL1286738 0.81 L3MBTL1 (0.35) BRD4KDM4EALDH1A1GSK3BPOLB
SCHEMBL8222280 0.81 L3MBTL1 (0.35) BRD4KDM4EALDH1A1GSK3BPOLB
SCHEMBL12062383 0.80 BRD4 (0.35) BRD4ALDH1A1RAB9ANPC1L3MBTL1
SCHEMBL8262291 0.80 F2 (0.39) BRD4RAB9ANPC1
SCHEMBL1286712 0.78 CDK1 (0.48) BRD4GSK3BRAB9ANPC1KMT2A
SCHEMBL8226019 0.77 CFD (0.51) CFDKDM4EALDH1A1GAAGSK3B
SCHEMBL8214922 0.75 CDK2 (0.64) KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256106-A1 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators Astex Therapeutics Limited (GB) 2010-12-01 EP disclosed
WO-2008007122-A2 COMBINATIONS OF PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDKS AND GSK'S ASTEX THERAPEUTICS LIMITED (GB) 2008-01-17 WO disclosed